Life-Sciences-Europe.com
The European Life Sciences Web Portal

This is a free web portal for the life sciences in Europe and Israel... » read more

Labfolder Acquires Cubuslab and Becomes Labforward (2019-05-22)
labfolder GmbH from Berlin and the cubuslab GmbH from Karlsruhe are merging. As a new company called Labforward, they jointly develop a manufacturer-independent platform for the integration of laboratory equipment and laboratory control software. The result is an i...
Quell Therapeutics Launches with £35m Series A Financing (2019-05-20)
King's and University College London (UCL) announce the foundation of a new spin-out company called Quell Therapeutics Limited. This new cell therapy company has been founded by a £35 million commitment Series A financing by Syncona who committed £34 million wit...
Rinri Therapeutics: £1.4m Seed Round Led by BIVF & UCB (2019-05-20)
Rinri Therapeutics, a biotechnology company developing a novel cellbased therapy to restore hearing, announced today that it successfully secured £1.4 million in seed funding. The financing, which was co-led by Boehringer Ingelheim Venture Fund and UCB Ventures and...
Fine Chemicals Companies Biosynth & Carbosynth Merge (2019-05-20)
Biosynth and Carbosynth announced their merger as a major step in consolidating their positions as leading suppliers in the constantly evolving fine chemical market, where mergers and acquisitions amongst the customer base of both companies have been a regular part...
Evotec to Acquire Just Biotherapeutics for up top $90m (2019-05-20)
> EVOTEC'S OFFERING OF INTEGRATED SOLUTIONS EXTENDED TO BIOLOGICS > ADDITION OF LONGSTANDING BIOLOGICS EXPERTISE BASED ON KEY TALENTS, INNOVATIVE ML (MACHINE LEARNING) DRIVEN TECHNOLOGIES AND SOPHISTICATED PROCESSES > EXPANDING EVOTEC'S US FOOTPRINT IN SEATTL...
DNA Script Raises $38.5m Series B Round Led by LSP (2019-05-16)
Oversubscribed round led by LSP will fund accelerated product development and commercial operations in the U.S. DNA Script today announced an oversubscribed Series B fundraising of $38.5M led by LSP, one of Europe’s largest and most experienced healthcare inve...
Qiagen & Inovio Partner to Develop CDx for Immunotherapy (2019-05-16)
Liquid biopsy-based Precision Medicine test to guide patient selection for Inovio’s VGX-3100 QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and Inovio Pharmaceuticals Inc. (NASDAQ: INO) today announced a collaboration to co-develop a companion diagnos...
Roche: FDA Apporves 1st-Line Venclexta/Gazyva Combi for CLL (2019-05-16)
> Fixed 12-month treatment with Venclexta plus Gazyva significantly reduced risk of disease progression or death by 67% compared to a current standard-of-care > Approval for expanded use of Venclexta offers more adults with chronic lymphocytic leukaemia a new tr...
MorphoSys: Phase 2 of MOR208 & Lenalidomide Meets Endpoint (2019-05-16)
> Primary analysis of L-MIND trial of tafasitamab (MOR208) plus lenalidomide in relapsed or refractory (r/r) DLBCL confirms overall strong data reported previously from this trial > Objective response rate (ORR) of 60%, complete response (CR) rate of 43% > Me...
Illumina Files Patent Suit against BGI in Denmark (2019-05-15)
Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed another patent infringement suit against one of BGI Group’s subsidiaries, BGI Europe A/S. Illumina filed suit in the Maritime & Commercial High Court of Denmark. “As we have previously stated, Illum...

» Show all News!"

Life-Sciences-Europe.com is your doorway to the European life sciences!

[LSE] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!

Start here with the latest News!

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]